Literature DB >> 2677252

A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

J M Rozemuller1, P Eikelenboom, F C Stam, K Beyreuther, C L Masters.   

Abstract

This study was designed to investigate the role of serum proteins, microglia, glial fibrillary acidic protein (GFAP) positive cells and dystrophic neurites in the genesis of cerebral amyloid. Using A4 protein antisera, we found an amorphous non-congophilic, form of plaque, which was not seen in Bielschowsky silver staining or Bodian impregnations. GFAP-positive glial cells, cells immunolabelled for some macrophage markers and dystrophic neurites were detected in congophilic plaques with crystalline amyloid, but not in the amorphous, non-congophilic plaques. The presence of alpha l-antichymotrypsin, complement factors and P component, but not of common serum proteins in both the amorphous and congophilic plaques, indicates that these three proteins may have a pathogenetic role in amyloid formation. Amorphous plaques may be the earlier forms of plaque and consequently, the presence of reactive cells and dystrophic neurites may be secondary phenomena.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677252     DOI: 10.1097/00005072-198911000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  62 in total

1.  The chronological characteristics of SOD1 activity and inflammatory response in the hippocampi of STZ-induced type 1 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Dae Won Kim; Jae Hoon Shin; Sung Min Nam; Jung Hoon Choi; Choong Hyun Lee; Moo-Ho Won; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2010-10-06       Impact factor: 3.996

2.  Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

Authors:  S A Frautschy; G M Cole; A Baird
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

3.  Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex.

Authors:  T G Beach; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.

Authors:  John F Reilly; Dora Games; Russell E Rydel; Stephen Freedman; Dale Schenk; Warren G Young; John H Morrison; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

5.  Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia.

Authors:  I Grundke-Iqbal; J Fleming; Y C Tung; H Lassmann; K Iqbal; J G Joshi
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Tatsuya Segawa; Masahiro Maeda; Nobuhiro Maruyama; Noriaki Kinoshita; Huayan Hou; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

7.  Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer's patients with tacrine transaminitis.

Authors:  V J Green; M Pirmohamed; N R Kitteringham; M J Knapp; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

8.  Argyrophilic plaque-like deposits in children.

Authors:  B J Crain; L McPhatter; D W Croom; C M Hulette
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

Authors:  M A Morán; E J Mufson; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.